AI-Powered Drug Repurposing for Pandemic Preparedness and Response

Abstract

Abstract: The emergence of novel infectious diseases, such as the COVID-19 pandemic, has highlighted the need for innovative approaches to drug discovery and development. Artificial intelligence (AI) has emerged as a powerful tool in this endeavor, offering the potential to accelerate drug repurposing processes and expedite the identification of potential treatments for pandemics. This paper explores the application of AI in drug repurposing during pandemic responses, delving into its methodologies, challenges, and ethical considerations. Additionally, it assesses the role of AI in current and future pandemic preparedness efforts, emphasizing the importance of collaboration between researchers, healthcare institutions, and pharmaceutical companies. Through a comprehensive review of the literature and case studies, this paper aims to provide a holistic understanding of AI's impact on drug repurposing in the context of pandemic response.